| 摘要 |
<p>The present invention relates to compounds defined by formula (I) wherein the variables R1, R2, R3, m, and n are defined as in claim 1, possessing valuable pharmacological activity. Particularly, the compounds are activators of the receptor GPR40 and thus are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.</p> |
| 申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH;HIMMELSBACH, FRANK;BAKKER, REMKO;ECKHARDT, MATTHIAS;HAMPRECHT, DIETER;LANGKOPF, ELKE;WAGNER, HOLGER |
发明人 |
HIMMELSBACH, FRANK;BAKKER, REMKO;ECKHARDT, MATTHIAS;HAMPRECHT, DIETER;LANGKOPF, ELKE;WAGNER, HOLGER |
